JRJ
ALBO

Jeffrey R. Jay’s Albireo Pharma Inc ALBO Stock Holding History

Jeffrey R. Jay’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$7.75M Buy
+61,795
New +$6.43M 6.12% 4

Other funds holding ALBO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Jeffrey R. Jay's ALBO Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in Albireo Pharma Inc (ALBO) in Q2 2013: 61,795 shares worth $7.75M. The stake represents 6.12% of the portfolio and ranks #4 among its holdings.

42 funds tracked by Wall St. Rank hold ALBO as of Q2 2013.

  • Jeffrey R. Jay held 61,795 shares of Albireo Pharma Inc worth $7.75M as of Q2 2013.
  • Albireo Pharma Inc was a new Jeffrey R. Jay position in Q2 2013.
  • Albireo Pharma Inc made up 6.12% of Jeffrey R. Jay's portfolio in Q2 2013, its #4 holding.
  • 42 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.